A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants
study id #: NCT00418821
condition: Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome, Scheie
status: Recruiting
purpose:The purpose of this study is to determine if laronidase is present in the breast milk of post-partum women receiving Aldurazyme® (laronidase) and the effects of Aldurazyme (laronidase) on the growth, development, and immunologic response of their breastfed infants.
intervention: Aldurazyme (laronidase)
results: https://clinicaltrials.gov/ct2/show/results/NCT00418821
last updated: February 26, 2022
-
MPS IV MorquioWhat is MPS IV?MPS IV, known as Morquio ...
-
Damage of the Cardiovascular System in Lysosomal Storage Disease – MucopolysaccharidosisThe analysis of literature data reflecti...
-
CHOC-Harbor UCLA MPS Multidisciplinary CenterCHOC and Harbor-UCLA Pediatrics together...
-
What Is MPS IX or Natowicz Disease?MPS IX, known as Natowicz disease, is on...
-
Spectrum of MPS 1 H/S Diseasehttps://www.onempsvoice.com/wp-content/u...
-
Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities fo...Mucopolysaccharidosis type II (MPS II) r...
-
Clinical Outcomes of Laminoplasty for Patients With Lysosomal Storage Disease Including Mucopolysaccharidosis and Mu...Although the clinical efficacy of lamino...